| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |